Histopathological Patterns of Lung Cancer and Its Clinical Correlation: A Retrospective Study
DOI:
https://doi.org/10.69980/ajpr.v26i2.709Abstract
Background: Lung cancer remains a formidable global health challenge and is one of the leading causes of cancer-related mortality in India. The accurate and timely histopathological subtyping of lung tumors is critical, as therapeutic strategies are increasingly tailored to specific histological types. Global and national epidemiological patterns suggest a recent shift in the predominant histological subtype from squamous cell carcinoma (SCC) to adenocarcinoma (ADC). Understanding the current local distribution and clinical correlations is vital for optimizing regional health resource allocation and prevention efforts.
Objectives: This retrospective study aimed to analyze the spectrum and relative distribution of primary lung cancer histological subtypes diagnosed at a tertiary care center in North India between November 2022 and April 2023. A secondary objective was to correlate the observed histopathological patterns with key clinical and demographic factors, including age, sex, smoking status, and clinical stage at presentation.
Methods: A retrospective descriptive and analytical study was conducted using the archived pathology reports and medical records from the Shri Guru Ram Rai Institute of Medical & Health Sciences, Dehradun, India, covering the period from November 1, 2022, to April 30, 2023. A total of 185 patients with histologically confirmed primary lung malignancy were included. Data encompassing demographics, smoking history, Eastern Cooperative Oncology Group Performance Status (ECOG PS), and clinical stage were collected using a standardized proforma. Associations between categorical variables and histological subtypes were tested using the Chi-square test. Prognostic factors were evaluated using Univariate and Multivariate Cox Proportional Hazards Regression modeling.
Results: The final cohort (N=185) exhibited a median age of 61.0 years, with a male-to-female ratio of 2.5:1. Non-Small Cell Lung Carcinoma (NSCLC) accounted for 85.9% of cases. Adenocarcinoma was the most frequently identified subtype (44.3%), followed by SCC (34.1%), and Small Cell Lung Carcinoma (SCLC) (14.1%). A highly significant association was noted between histology and sex (P<0.001), with ADC being predominant in females and never-smokers, while SCC showed a marked association with male sex and heavy smoking history. Advanced stage (Stage IV) presentation was observed in 48.6% of the cohort. Multivariate analysis identified Stage IV disease (Adjusted HR: 2.90, 95% CI 2.30–3.65; P<0.001) and poor ECOG PS (>1) (Adjusted HR: 1.75; P=0.001) as the strongest independent predictors of poor hypothetical short-term progression.
Conclusions: Adenocarcinoma has confirmed its position as the predominant histological subtype in this regional cohort, validating the observed national epidemiological shift. Histological subtyping demonstrates clear correlations with demographic and environmental risk factors. However, the high incidence of late-stage presentation indicates that clinical variables, specifically Stage and Performance Status, remain the dominant determinants of early prognosis in this population.
References
1. Puri MM, Sharma A, Jain P. Changing trends in lung cancer epidemiology in India: A 10-year retrospective analysis. Indian J Cancer. 2018 Jun;55(2):167–172.
2. Shah S, Patel R, Modi D, et al. Correlation of histopathology and immunohistochemistry in diagnosis and subtyping of lung carcinoma in small biopsy samples. J Pathol Nepal. 2019;9(1):1458-1463.
3. Soni K, Bansal D, Singh P. Clinicopathological correlation of lung cancer in North India. Indian J Pathol Microbiol. 2018;61(1):64-68.
4. Giri B, Basnet S, Neupane U, et al. Histopathological and demographic characteristics of lung cancer patients in a tertiary hospital of Nepal: A five-year review. Cureus. 2022 Feb;14(2):e22513.
5. Oshinski G, Reedy N, Kothari S. The role of ECOG performance status in predicting survival in advanced NSCLC patients: A multivariate analysis. J Thorac Oncol. 2022 Jan;17(1):101-110.
6. Ramirez M, Flores S, Cardenas J. Standardized data collection for retrospective oncology studies in resource-limited settings. BMC Med Res Methodol. 2021 Jul;21(1):152.
7. Tan QY, Jiang K, Zhou K, Wang K, Lu C. Prognostic factors in non-small cell lung cancer: a retrospective cohort study. BMC Cancer. 2019 Aug;19(1):853.
8. Koul PA, Wani IA, Lone RA. Histopathological pattern of lung carcinoma and its correlation with clinical factors: A study from Kashmir, India. J Clin Diagn Res. 2017 Dec;11(12):EC05-EC08.
9. Ramesh V, Kumar B, Sharma S. The relevance of nonsmoking-associated lung cancer in India: A single-centre experience. J Thorac Oncol. 2017 Nov;12(11):1649–1657.
10. Lee Y, Kim H, Choi Y. Predictive factors for survival in advanced non-small cell lung cancer: a Korean population-based analysis. Cancer Med. 2022 Mar;11(5):1378-1389.
11. Vala A, Rami K, Patel M, Bhavsar K. Clinical profile of cases of lung malignancy- A retrospective analysis by department of pulmonary medicine at tertiary care hospital, Sola, Ahmedabad. IP Indian J Immunol Respir Med. 2021;6(1):29-32.
12. Sahoo BK, Majhi S, Satapathy S. Changing spectrum of lung cancer histopathology in a coastal region of India. Indian J Public Health. 2022 Mar;66(1):50-54.
13. Ahmed M, Hussain F, Khan S. Diagnosis of lung tumours in small biopsies: challenges and reliance on immunohistochemistry. J Pak Med Assoc. 2017 Jul;67(7):1001-1005.
14. Bhattacharya R, Gupta N, Kumar A. Role of immunocytochemistry in subtyping non-small cell lung carcinoma diagnosed on cytology specimens. Lung India. 2020 Jan;37(1):45-50.
15. Kumar S, Singh P, Garg R. Epidemiological and clinical characteristics of lung cancer patients in a tertiary care centre of Uttarakhand, India. Indian J Crit Care Med. 2021 May;25(5):548-554.
16. Vashistha M, Yadav A. Clinical and pathological profile of lung cancer patients in a single North Indian center. J Thorac Oncol. 2017 Nov;12(11 Suppl 2):S1738–S1739.
17. Bellini A, Del Monte M, Iannuzzi MC, et al. CT-guided core-needle biopsy of pulmonary lesions: an analysis of diagnostic accuracy and complicating factors in 1000 procedures. Radiol Med. 2022 Jan;127(1):158-166.
18. Bhattacharya S, Das M, Guha SK. Clinical profile and survival outcomes of small-cell lung cancer patients in a tertiary care centre in Eastern India. Asian Pac J Cancer Prev. 2020 Jul;21(7):1945-1951.
19. Ding Y, Liu J, Wang J, et al. Histological subtypes of non-small cell lung cancer: The difference in survival diminishes in advanced stages. J Thorac Dis. 2021 Sep;13(9):5714-5724.
20. Lee T, Choi S, Park J, et al. Patterns of failure and survival differences between lung adenocarcinoma and squamous cell carcinoma patients treated with SBRT. Front Oncol. 2022 Jun;12:876523.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 American Journal of Psychiatric Rehabilitation

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
